{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T15:03:29Z","timestamp":1648998209582},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.5414\/cp203395r","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T16:54:30Z","timestamp":1549817670000},"page":"273-274","source":"Crossref","is-referenced-by-count":0,"title":["Safety of drug combinations based on psychoactive agents in the treatment of obesity (A reply by the authors)"],"prefix":"10.5414","volume":"57","author":[{"given":"Juan Gerardo","family":"Reyes-Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T12:44:28Z","timestamp":1555332268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=18086&doi=10.5414\/CP203395R&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":0,"journal-issue":{"issue":"05","published-print":{"date-parts":[[2019]]}},"alternative-id":["203395"],"URL":"https:\/\/doi.org\/10.5414\/cp203395r","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}